Institutional Ownership Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA). We have compiled data on the 314 institutions that hold shares in the stock, with a total of 241 Million shares, which have been reported (via 13F filing form) to have a value of $1.89 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
27,313,967
shares
|
$213 Million
0.0% of portfolio
|
Q3 2024
Added 5.25%
|
|
Perceptive Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
26,617,709
shares
|
$208 Million
6.53% of portfolio
|
Q3 2024
Added 2.64%
|
|
Mhr Fund Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
23,997,103
shares
|
$187 Million
28.52% of portfolio
|
Q1 2024
Added 20.0%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
21,225,119
shares
|
$166 Million
0.0% of portfolio
|
Q2 2024
Added 6.5%
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
13,201,978
shares
|
$103 Million
0.01% of portfolio
|
Q3 2024
Added 4.57%
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
8,528,500
shares
|
$66.6 Million
6.8% of portfolio
|
Q3 2024
Added 12.99%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Nov 14, 2024 Q3 2024 |
8,144,637
shares
|
$63.6 Million
1.42% of portfolio
|
Q3 2024
Added 198.07%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
5,861,279
shares
|
$45.8 Million
0.03% of portfolio
|
Q3 2024
Added 185.85%
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
5,648,995
shares
|
$44.1 Million
0.0% of portfolio
|
Q3 2024
Reduced 2.38%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
5,175,080
shares
|
$40.4 Million
0.04% of portfolio
|
Q2 2023
Added 436.67%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2024 Q3 2024 |
4,803,825
shares
|
$37.5 Million
0.07% of portfolio
|
Q3 2024
Reduced 6.02%
|
|
Long Focus Capital Management, LLC
San Juan, PR |
Nov 13, 2024 Q3 2024 |
4,532,000
shares
|
$35.4 Million
1.56% of portfolio
|
Q3 2024
Added 9.68%
|
|
Balyasny Asset Management LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
4,472,576
shares
|
$34.9 Million
0.07% of portfolio
|
Q3 2024
Reduced 1.5%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
4,390,032
shares
|
$34.3 Million
0.01% of portfolio
|
Q3 2024
Added 67.44%
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
4,240,000
shares
|
$33.1 Million
0.6% of portfolio
|
Q3 2024
Reduced 63.76%
|
|
Principal Financial Group Inc
Des Moines, IA |
Oct 31, 2024 Q3 2024 |
4,033,184
shares
|
$31.5 Million
0.02% of portfolio
|
Q3 2024
Added 59.02%
|
|
Macquarie Group LTD
Australia, C3 |
Nov 14, 2024 Q3 2024 |
3,190,036
shares
|
$24.9 Million
0.03% of portfolio
|
Q3 2024
New holding
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
3,102,912
shares
|
$24.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 10.9%
|
|
Palo Alto Investors LP
Palo Alto, CA |
Nov 14, 2024 Q3 2024 |
3,041,685
shares
|
$23.8 Million
3.93% of portfolio
|
Q3 2024
Added 43.72%
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
2,450,838
shares
|
$19.1 Million
0.0% of portfolio
|
Q3 2024
Added 13.09%
|
|
Bio Impact Capital LLC
Cambridge, MA |
Nov 12, 2024 Q3 2024 |
2,406,714
shares
|
$18.8 Million
3.53% of portfolio
|
Q3 2024
Added 1.69%
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
2,248,576
shares
|
$17.6 Million
0.0% of portfolio
|
Q3 2024
Added 3.77%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
2,148,574
shares
|
$16.8 Million
0.0% of portfolio
|
Q3 2024
Reduced 23.89%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
2,069,592
shares
|
$16.2 Million
0.0% of portfolio
|
Q3 2024
Reduced 8.65%
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
2,008,046
shares
|
$15.7 Million
0.03% of portfolio
|
Q1 2024
Reduced 28.65%
|